Title |
Cautionary optimism: caffeine and Parkinson’s disease risk
|
---|---|
Published in |
Journal of Clinical Movement Disorders, June 2016
|
DOI | 10.1186/s40734-016-0037-8 |
Pubmed ID | |
Authors |
Leonard L. Sokol, Michael J. Young, Alberto J. Espay, Ronald B. Postuma |
Abstract |
Most Parkinson's disease (PD) patients present without known family history and without a diagnosed prodromal phase, underscoring the difficulty of employing primary (neuroprevention) and secondary (neuroprotection) preventions. In cases of monogenic forms, however, potential gene-carrying family members of a proband could engage in neuroprevention, such as exercise or diet modifications, to attenuate the risk of, or delay, disease development. However, a historical lack of recognized disease-modifying interventions has limited clinicians' ability to recommend reliable preventive measures in caring for at-risk populations. We briefly analyze the first retrospective study to examine caffeine consumption and PD risk in a LRRK2 R1628P cohort. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 17 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 3 | 18% |
Student > Bachelor | 3 | 18% |
Lecturer | 2 | 12% |
Librarian | 1 | 6% |
Student > Doctoral Student | 1 | 6% |
Other | 2 | 12% |
Unknown | 5 | 29% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 4 | 24% |
Biochemistry, Genetics and Molecular Biology | 1 | 6% |
Business, Management and Accounting | 1 | 6% |
Nursing and Health Professions | 1 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 6% |
Other | 4 | 24% |
Unknown | 5 | 29% |